Transparency and accountability around patient outcomes requires that practitioners take a uniform approach to assessing treatment outcomes. Reporting on quality outcomes is rapidly becoming the norm and expected by healthcare patients worldwide. For behavior analysts, this increased attention on treatment outcomes calls for practitioners to demonstrate that their treatments work and to become more accountable for the costs of treatment. A previous webinar by Dr. Ellie Kazemi focused on a systematic approach to selecting instruments to assess and plan treatment for individuals diagnosed with Autism Spectrum Disorders (ASD). But, it’s one thing to conduct assessments, and another thing entirely to do something with the resulting data. In this webinar, Dr. Cox highlights considerations and planning activities that practitioners should be aware of so that they can efficiently store, manage, analyze, and communicate patient outcomes to relevant stakeholders. To get the most out of this webinar, it is recommended audience members have view two previous webinars put forth by BHCOE:
1.5 BACB CEUs are offered for this webinar. CEUs are $20 for non-members and free for BHCOE-accredited organizations and members.
In order to be eligible for BACB CEUs, participants must attend the event online to ensure the participant accesses both the audio and visual portions of the presentation. Dial in can be used to supplement the audio features of the webinar only. Participants attending the webinar by dial-in only will not be eligible for CEUs. Additionally, participants must attend the webinar for a minimum of 50 minutes in order to be eligible for 1 CEU (25 minutes for .5 CEUs). CEUs are only processed for live attendance of the event. Once purchased, no refunds will be issued. If a CE webinar is canceled due to low enrollment or other unforeseen circumstances, the registrant receives an automatic 100% refund at the time of cancellation.
About the Presenter
Dr. David Cox, Chief Data Officer, BHCOE
Dr. Cox has worked in behavior analysis since 2006 and with populations spanning ASD, intellectual disabilities, schizophrenia, and individuals seeking to change pro-health behavior (e.g., diet, physical activity, substance use). He has a MS in Bioethics, a PhD in Behavior Analysis, and post-doctoral training in behavioral pharmacology, behavioral economics, and data science. Dr. Cox’s work focuses broadly on behavioral data science – combining big data analytics and artificial intelligence with behavior analysis to describe, predict, and control health-related decision-making.